Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

       
Total article views   HTML views PDF downloads Totals
9,153 Dovepress* 8,547+ 1,295 9,842
PubMed Central* 606 290 896
Totals 9,153 1,585 10,738
*Since 10 August 2015
+Since July 2016

View citations on PubMed Central and Google Scholar